Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Metabolism and Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2133/DMPK.DMPK-12-SH-093PMID 23149872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.

  2010cited by this paper
• The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics

  2010cited by this paper
• Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

  2010cited by this paper
• Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters.

  2009cited by this paper
• The role of hepatic transporters in drug elimination

  2008cited by this paper
• Calcineurin Inhibitor Sparing in Renal Transplantation

  2008cited by this paper
• Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer

  2008cited by this paper
• Genetic variations and gene expression of transporters in drug disposition and response

  2008cited by this paper
• Variants in the SLCO1B3 Gene: Interethnic Distribution and Association with Paclitaxel Pharmacokinetics

  2007cited by this paper
• Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.

  2007cited by this paper
• 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation

  2007cited by this paper
• Pharmacogenomics of human OATP transporters

  2006cited by this paper
• Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

  2006cited by this paper
• Polymorphisms and linkage disequilibrium of the OATP8 (OATP1B3) gene in Japanese subjects.

  2006cited by this paper
• Calcineurin inhibitor sparing in renal transplantation

  2006cited by this paper
• The organic anion transporter (OATP) family.

  2004cited by this paper
• Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties

  2004cited by this paper
• Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8).

  2004cited by this paper
• Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins

  2003cited by this paper
• Pharmacogenomics--drug disposition, drug targets, and side effects.

  2003cited by this paper
• LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

  2001cited by this paper
• Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide*

  2000cited by this paper
• Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

  2000cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Low systemic exposure to tacrolimus correlates with acute rejection.

  1999cited by this paper
• Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.

  1998cited by this paper
• Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine

  1998cited by this paper

• Association Study of OATP1B3 Polymorphisms on Hepatic Uptake and Drug–Drug Interaction In Vitro

  2025cites this paper
• Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy

  2024cites this paper
• Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung Transplantation

  2024cites this paper
• Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury

  2022cites this paper
• Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease

  2022cites this paper
• Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients

  2022cites this paper
• Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients

  2021cites this paper
• Impacts of SNPs on adverse events and trough concentration of imatinib in patients with gastrointestinal stromal tumors.

  2021cites this paper
• Monitoring Intra-cellular Tacrolimus Concentrations in Solid Organ Transplantation: Use of Peripheral Blood Mononuclear Cells and Graft Biopsy Tissue

  2021cites this paper
• Role of Genetic Variations in the Hepatic Handling of Drugs

  2020cites this paper
• Unraveling ‘The Cancer Genome Atlas’ information on the role of SLC transporters in anticancer drug uptake

  2019cites this paper
• Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients

  2019cites this paper
• Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations.

  2018cites this paper
• OATP1B3 (699G>A) and CYP2C9*2, *3 significantly influenced the transport and metabolism of glibenclamide and glipizide

  2018cites this paper
• Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation

  2018cites this paper
• Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters

  2018cites this paper
• "What do we know about tacrolimus pharmacogenetics in transplant recipients?"

  2018cites this paper
• Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.

  2018cites this paper
• Influence of the SLCO1B3 Gene on Sulfonylurea Failure in Patients with Type 2 Diabetes in China.

  2017cites this paper
• Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients.

  2017cites this paper
• Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype

  2016cites this paper
• Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?

  2016cites this paper
• Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

  2013cites this paper